The global radiofrequency ablation devices market is expected to exceed US$ 9 billion by 2021. The emergence of next-generation ablation products and technologies, increasing number of ablation procedures, and rising number of hospitals, surgical, and ablation centers are expected to drive the market. In addition, the rising incidence of cancer and growing prevalence of cardiovascular diseases are fueling the growth of the market. However, reuse and reprocessing of devices in developing countries, healthcare cost-containment measures, and an unfavorable regulatory scenario are hampering the growth of the market.
In this report, the global radiofrequency ablation devices market is segmented by type, product, application, and region. On the basis of type, the market is segmented into light/laser ablation, hydrothermal ablation, radiofrequency ablation, microwave ablation, electrical ablation, cryoablation, and ultrasound ablation. The market on the basis of product is segmented into disposable equipment, reusable equipment, and capital equipment. The disposable equipment product segment is divided into radiofrequency ablation single use electrodes, radiofrequency ablation single-use probes, radiofrequency ablation needles, and radiofrequency ablation cannulas. Radiofrequency ablation electrodes and radiofrequency ablation probes fall under the reusable equipment product segment. The capital equipment product segment is categorized into radiofrequency ablation generator. The market by application is segmented into surgical oncology, cosmetology, hypertension, gynecology, pain management, and cardiology and cardiac rhythm management
The global radiofrequency ablation devices market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, and Rest of the World. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional radiofrequency ablation devices market and analyzes the variations in the growth of the industry in certain regions.
A glimpse of the report structure is provided in the report description available on the website.
Stryker Corp., Accuray, St. Jude Medical Inc., Neurotherm Inc., Biosense Webster, Diros Technology Inc., Cosman Medical Inc., and Kimberly-Clark Corporation are the most active players in the radiofrequency ablation devices market.
This report covers the radiofrequency ablation devices market, in terms of value, and forecasts the market size till 2021. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
The deep-dive study on the radiofrequency ablation devices market will help customers with identifications of new market opportunities and targeted promotional plans.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com